Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Diversion | 21 | 2017 | 43 | 2.740 |
Why?
|
Urinary Reservoirs, Continent | 13 | 2012 | 24 | 2.550 |
Why?
|
Penile Neoplasms | 13 | 2019 | 33 | 2.000 |
Why?
|
Organ Sparing Treatments | 5 | 2019 | 36 | 1.570 |
Why?
|
Adrenal Gland Neoplasms | 8 | 2019 | 67 | 1.370 |
Why?
|
Kidney Neoplasms | 15 | 2019 | 433 | 1.340 |
Why?
|
Adrenalectomy | 3 | 2019 | 37 | 1.200 |
Why?
|
Penis | 14 | 2017 | 98 | 1.070 |
Why?
|
Pheochromocytoma | 6 | 2008 | 34 | 0.960 |
Why?
|
Urologic Surgical Procedures, Male | 5 | 2019 | 37 | 0.910 |
Why?
|
Urinary Incontinence | 4 | 2011 | 70 | 0.760 |
Why?
|
Urinary Bladder Diseases | 5 | 2017 | 35 | 0.740 |
Why?
|
Urethra | 24 | 2006 | 84 | 0.720 |
Why?
|
Urinary Bladder | 24 | 2017 | 245 | 0.710 |
Why?
|
Nephrectomy | 10 | 2019 | 178 | 0.690 |
Why?
|
Carcinoma, Renal Cell | 3 | 2017 | 238 | 0.680 |
Why?
|
Adrenal Glands | 2 | 2019 | 43 | 0.670 |
Why?
|
Testicular Neoplasms | 3 | 2019 | 132 | 0.620 |
Why?
|
Prostatic Neoplasms | 10 | 2019 | 1548 | 0.610 |
Why?
|
Ileum | 14 | 2011 | 132 | 0.570 |
Why?
|
Ureteral Obstruction | 11 | 2013 | 105 | 0.540 |
Why?
|
Urinary Fistula | 5 | 2012 | 20 | 0.520 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 13 | 0.520 |
Why?
|
Urinary Bladder Neoplasms | 9 | 2019 | 557 | 0.510 |
Why?
|
Printing, Three-Dimensional | 1 | 2016 | 69 | 0.480 |
Why?
|
Vesico-Ureteral Reflux | 5 | 2011 | 81 | 0.450 |
Why?
|
Humans | 153 | 2019 | 124672 | 0.440 |
Why?
|
Male | 114 | 2019 | 61242 | 0.420 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2013 | 19 | 0.420 |
Why?
|
Pelvic Neoplasms | 1 | 2013 | 21 | 0.420 |
Why?
|
Vaginal Fistula | 1 | 2012 | 3 | 0.410 |
Why?
|
Urology | 3 | 2017 | 75 | 0.400 |
Why?
|
Vagina | 2 | 2012 | 194 | 0.390 |
Why?
|
Dextrans | 1 | 2011 | 45 | 0.370 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2005 | 256 | 0.360 |
Why?
|
Medical Illustration | 1 | 2011 | 18 | 0.360 |
Why?
|
Biocompatible Materials | 1 | 2011 | 118 | 0.350 |
Why?
|
Hyaluronic Acid | 1 | 2011 | 95 | 0.350 |
Why?
|
Urinary Bladder, Neurogenic | 3 | 2010 | 46 | 0.340 |
Why?
|
Surgical Flaps | 5 | 2010 | 204 | 0.340 |
Why?
|
Urinary Bladder, Overactive | 1 | 2010 | 28 | 0.330 |
Why?
|
Scrotum | 3 | 2007 | 24 | 0.320 |
Why?
|
Urologic Surgical Procedures | 5 | 2011 | 58 | 0.310 |
Why?
|
Tomography, X-Ray Computed | 4 | 2015 | 2091 | 0.300 |
Why?
|
Prostatectomy | 9 | 2019 | 344 | 0.300 |
Why?
|
Appendix | 4 | 2011 | 15 | 0.290 |
Why?
|
Urodynamics | 3 | 2011 | 40 | 0.290 |
Why?
|
Mesentery | 1 | 2007 | 28 | 0.280 |
Why?
|
Ileostomy | 1 | 2007 | 31 | 0.280 |
Why?
|
Colon, Transverse | 1 | 2007 | 6 | 0.270 |
Why?
|
Counseling | 1 | 2008 | 217 | 0.270 |
Why?
|
Follow-Up Studies | 17 | 2008 | 5147 | 0.250 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2006 | 668 | 0.250 |
Why?
|
Patient Education as Topic | 1 | 2008 | 441 | 0.240 |
Why?
|
Quality of Life | 2 | 2017 | 1935 | 0.240 |
Why?
|
Middle Aged | 52 | 2019 | 26760 | 0.230 |
Why?
|
Hemangioma | 3 | 1994 | 94 | 0.230 |
Why?
|
Ureteral Neoplasms | 3 | 2019 | 25 | 0.230 |
Why?
|
Minimally Invasive Surgical Procedures | 2 | 2019 | 201 | 0.220 |
Why?
|
Urinary Tract | 6 | 1979 | 60 | 0.220 |
Why?
|
Adult | 51 | 2012 | 29475 | 0.220 |
Why?
|
Stomach | 3 | 2004 | 272 | 0.210 |
Why?
|
Omentum | 3 | 1992 | 47 | 0.210 |
Why?
|
Vena Cava, Inferior | 3 | 2003 | 103 | 0.210 |
Why?
|
Treatment Outcome | 14 | 2019 | 12327 | 0.210 |
Why?
|
Androgens | 1 | 2005 | 274 | 0.210 |
Why?
|
Vascular Neoplasms | 1 | 2003 | 32 | 0.200 |
Why?
|
Circumcision, Male | 3 | 2006 | 25 | 0.200 |
Why?
|
Muscle, Smooth | 9 | 1980 | 135 | 0.190 |
Why?
|
Urethral Stricture | 7 | 1986 | 13 | 0.190 |
Why?
|
Urinary Tract Infections | 2 | 2005 | 302 | 0.190 |
Why?
|
Female | 52 | 2013 | 66542 | 0.190 |
Why?
|
Pain | 2 | 2004 | 461 | 0.180 |
Why?
|
Perineum | 6 | 2010 | 48 | 0.180 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 959 | 0.180 |
Why?
|
Colon | 4 | 2007 | 349 | 0.170 |
Why?
|
Estramustine | 1 | 2000 | 4 | 0.170 |
Why?
|
Aged | 30 | 2019 | 19740 | 0.170 |
Why?
|
Urethral Neoplasms | 3 | 1994 | 9 | 0.170 |
Why?
|
Endoscopy | 5 | 1994 | 280 | 0.160 |
Why?
|
Life Expectancy | 1 | 2019 | 53 | 0.160 |
Why?
|
Prostate-Specific Antigen | 1 | 2000 | 256 | 0.150 |
Why?
|
Ablation Techniques | 1 | 2019 | 31 | 0.150 |
Why?
|
Vesicovaginal Fistula | 2 | 1992 | 10 | 0.150 |
Why?
|
Intraoperative Care | 1 | 1998 | 106 | 0.150 |
Why?
|
Surgical Stomas | 1 | 1998 | 10 | 0.150 |
Why?
|
Umbilicus | 1 | 1998 | 13 | 0.150 |
Why?
|
Urinary Catheterization | 9 | 2007 | 81 | 0.150 |
Why?
|
Adenocarcinoma | 7 | 1995 | 1023 | 0.150 |
Why?
|
Neoplasm Invasiveness | 3 | 2006 | 617 | 0.150 |
Why?
|
Ureteroscopy | 2 | 2008 | 17 | 0.150 |
Why?
|
Lithotripsy, Laser | 2 | 2008 | 12 | 0.140 |
Why?
|
Kidney | 6 | 2019 | 1358 | 0.140 |
Why?
|
Kidney Calculi | 6 | 1986 | 42 | 0.140 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 198 | 0.140 |
Why?
|
Empyema | 1 | 2017 | 24 | 0.140 |
Why?
|
Lipoma | 2 | 1993 | 24 | 0.140 |
Why?
|
Ureter | 8 | 1993 | 97 | 0.130 |
Why?
|
Dermatologic Surgical Procedures | 2 | 2007 | 45 | 0.130 |
Why?
|
Child | 19 | 2010 | 24379 | 0.130 |
Why?
|
Pelvis | 2 | 1995 | 71 | 0.130 |
Why?
|
Malacoplakia | 1 | 1995 | 3 | 0.120 |
Why?
|
SEER Program | 2 | 2019 | 202 | 0.120 |
Why?
|
Colon, Sigmoid | 1 | 1995 | 13 | 0.120 |
Why?
|
Ureterostomy | 1 | 1995 | 6 | 0.120 |
Why?
|
Diethylstilbestrol | 1 | 1995 | 142 | 0.120 |
Why?
|
Cystectomy | 2 | 2017 | 160 | 0.120 |
Why?
|
Methods | 13 | 1988 | 149 | 0.120 |
Why?
|
Kidney Diseases | 5 | 2007 | 480 | 0.120 |
Why?
|
Radiography | 17 | 1993 | 821 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2008 | 1233 | 0.120 |
Why?
|
Aged, 80 and over | 8 | 2017 | 6544 | 0.110 |
Why?
|
Adolescent | 17 | 2008 | 19282 | 0.110 |
Why?
|
Sclerotherapy | 1 | 1994 | 40 | 0.110 |
Why?
|
Urinary Bladder Fistula | 2 | 2010 | 4 | 0.110 |
Why?
|
Retrospective Studies | 10 | 2017 | 16318 | 0.110 |
Why?
|
Biopsy, Needle | 2 | 2008 | 231 | 0.100 |
Why?
|
Urologic Neoplasms | 1 | 1993 | 42 | 0.100 |
Why?
|
Postoperative Care | 2 | 2011 | 298 | 0.100 |
Why?
|
Spermatic Cord | 3 | 1977 | 12 | 0.100 |
Why?
|
Urogenital Neoplasms | 1 | 2012 | 15 | 0.100 |
Why?
|
Tuberous Sclerosis | 2 | 2008 | 120 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2017 | 1140 | 0.100 |
Why?
|
Mortality, Premature | 1 | 2012 | 12 | 0.100 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1993 | 163 | 0.090 |
Why?
|
Rheology | 1 | 2011 | 32 | 0.090 |
Why?
|
Urination | 3 | 1980 | 23 | 0.090 |
Why?
|
Calculi | 2 | 1983 | 15 | 0.090 |
Why?
|
Ureteral Calculi | 3 | 2008 | 15 | 0.090 |
Why?
|
Puberty | 1 | 2011 | 94 | 0.090 |
Why?
|
Radiation Injuries | 1 | 1992 | 142 | 0.090 |
Why?
|
Kidney Pelvis | 6 | 1975 | 44 | 0.090 |
Why?
|
Phenoxybenzamine | 3 | 2008 | 12 | 0.090 |
Why?
|
Survival Rate | 2 | 2008 | 2044 | 0.090 |
Why?
|
Time Factors | 5 | 2010 | 6293 | 0.090 |
Why?
|
Diverticulum | 3 | 1982 | 28 | 0.090 |
Why?
|
Rectus Abdominis | 1 | 2010 | 8 | 0.080 |
Why?
|
Neoplasm Staging | 3 | 2017 | 1251 | 0.080 |
Why?
|
Tissue Donors | 1 | 1993 | 494 | 0.080 |
Why?
|
Postoperative Complications | 8 | 2004 | 3065 | 0.080 |
Why?
|
Calcinosis | 3 | 2001 | 176 | 0.080 |
Why?
|
Prostheses and Implants | 2 | 1988 | 151 | 0.080 |
Why?
|
Angiomyolipoma | 1 | 2008 | 3 | 0.080 |
Why?
|
Lasers, Solid-State | 1 | 2008 | 17 | 0.070 |
Why?
|
Muscle Contraction | 5 | 1980 | 188 | 0.070 |
Why?
|
Sickness Impact Profile | 1 | 2008 | 36 | 0.070 |
Why?
|
Child, Preschool | 14 | 2008 | 14013 | 0.070 |
Why?
|
Prostate | 5 | 1977 | 435 | 0.070 |
Why?
|
Urography | 10 | 1978 | 31 | 0.070 |
Why?
|
Parasympathomimetics | 4 | 1980 | 7 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 1993 | 643 | 0.070 |
Why?
|
Castration | 2 | 2005 | 33 | 0.070 |
Why?
|
Ejaculation | 1 | 2007 | 20 | 0.070 |
Why?
|
Tramadol | 1 | 2007 | 10 | 0.070 |
Why?
|
Serotonin Agents | 1 | 2007 | 14 | 0.070 |
Why?
|
Coitus | 1 | 2007 | 20 | 0.070 |
Why?
|
Neurosurgery | 1 | 2008 | 74 | 0.070 |
Why?
|
Cystoscopy | 2 | 2005 | 44 | 0.070 |
Why?
|
Sus scrofa | 1 | 2007 | 125 | 0.070 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 1987 | 30 | 0.070 |
Why?
|
Genitalia, Female | 1 | 1987 | 47 | 0.070 |
Why?
|
Hernia | 1 | 1986 | 19 | 0.070 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2007 | 79 | 0.060 |
Why?
|
Ureteral Diseases | 2 | 1991 | 5 | 0.060 |
Why?
|
Urethral Diseases | 2 | 1983 | 17 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 54 | 0.060 |
Why?
|
Penile Diseases | 2 | 1975 | 11 | 0.060 |
Why?
|
Surgery, Plastic | 1 | 1987 | 111 | 0.060 |
Why?
|
Lymph Node Excision | 4 | 1994 | 164 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2007 | 186 | 0.060 |
Why?
|
Microtubule-Associated Proteins | 1 | 2006 | 244 | 0.060 |
Why?
|
Cystitis, Interstitial | 1 | 2004 | 2 | 0.060 |
Why?
|
Condylomata Acuminata | 2 | 1974 | 15 | 0.060 |
Why?
|
Granuloma | 2 | 1976 | 68 | 0.060 |
Why?
|
Carcinoma | 2 | 1977 | 286 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2008 | 1690 | 0.060 |
Why?
|
Sex Factors | 1 | 2008 | 1285 | 0.060 |
Why?
|
Urination Disorders | 4 | 1979 | 18 | 0.060 |
Why?
|
Cystitis | 1 | 2004 | 50 | 0.060 |
Why?
|
Sympathomimetics | 2 | 1980 | 12 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 341 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2007 | 475 | 0.050 |
Why?
|
Urinary Bladder Neck Obstruction | 3 | 1978 | 29 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1284 | 0.050 |
Why?
|
Intestinal Obstruction | 1 | 2004 | 94 | 0.050 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2002 | 4 | 0.050 |
Why?
|
Vaginal Diseases | 1 | 1983 | 17 | 0.050 |
Why?
|
Intestinal Fistula | 2 | 1991 | 28 | 0.050 |
Why?
|
Renal Veins | 2 | 2001 | 36 | 0.050 |
Why?
|
Thrombectomy | 1 | 2003 | 107 | 0.050 |
Why?
|
Cohort Studies | 2 | 2008 | 4797 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2006 | 669 | 0.050 |
Why?
|
Urethral Obstruction | 1 | 1982 | 56 | 0.050 |
Why?
|
Suture Techniques | 3 | 2010 | 196 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2004 | 759 | 0.050 |
Why?
|
Age Factors | 1 | 2008 | 2819 | 0.050 |
Why?
|
Varicose Veins | 1 | 2001 | 29 | 0.050 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2001 | 71 | 0.050 |
Why?
|
Reoperation | 1 | 2004 | 832 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 1268 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2005 | 717 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2003 | 183 | 0.040 |
Why?
|
Short Bowel Syndrome | 1 | 2001 | 65 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 1988 | 808 | 0.040 |
Why?
|
Wilms Tumor | 3 | 1995 | 113 | 0.040 |
Why?
|
Acidosis | 1 | 2001 | 93 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 2426 | 0.040 |
Why?
|
Congenital Abnormalities | 4 | 1975 | 254 | 0.040 |
Why?
|
Retroperitoneal Space | 3 | 1994 | 19 | 0.040 |
Why?
|
Testosterone | 1 | 2005 | 533 | 0.040 |
Why?
|
Animals | 15 | 2007 | 34064 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2006 | 2816 | 0.040 |
Why?
|
Pharmacology | 1 | 1979 | 10 | 0.040 |
Why?
|
Adrenergic Agents | 1 | 1979 | 12 | 0.040 |
Why?
|
Nephritis | 2 | 1976 | 20 | 0.040 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1979 | 48 | 0.040 |
Why?
|
Central Nervous System Agents | 1 | 1979 | 14 | 0.040 |
Why?
|
Pressure | 2 | 1998 | 128 | 0.040 |
Why?
|
Prostatic Hyperplasia | 3 | 1979 | 117 | 0.040 |
Why?
|
Hypertension | 1 | 2008 | 1321 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2003 | 1328 | 0.040 |
Why?
|
Renal Insufficiency | 1 | 2001 | 236 | 0.040 |
Why?
|
Risk Assessment | 1 | 2008 | 3441 | 0.040 |
Why?
|
Ganglionic Blockers | 1 | 1978 | 13 | 0.040 |
Why?
|
Prostatic Diseases | 1 | 1978 | 15 | 0.040 |
Why?
|
Ganglionic Stimulants | 1 | 1978 | 11 | 0.040 |
Why?
|
Radiotherapy | 1 | 2019 | 135 | 0.040 |
Why?
|
Triamcinolone | 1 | 1978 | 14 | 0.040 |
Why?
|
Neoplasm Grading | 1 | 2019 | 274 | 0.040 |
Why?
|
Mullerian Ducts | 1 | 1978 | 33 | 0.040 |
Why?
|
Cysts | 1 | 1978 | 101 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1979 | 243 | 0.040 |
Why?
|
Vascular Surgical Procedures | 1 | 2003 | 577 | 0.040 |
Why?
|
Blastomycosis | 1 | 1977 | 6 | 0.030 |
Why?
|
Anuria | 1 | 2017 | 13 | 0.030 |
Why?
|
Prostatitis | 1 | 1977 | 13 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2017 | 44 | 0.030 |
Why?
|
Muscles | 4 | 1979 | 289 | 0.030 |
Why?
|
Contracture | 1 | 1977 | 24 | 0.030 |
Why?
|
United States | 3 | 2019 | 10899 | 0.030 |
Why?
|
Inguinal Canal | 1 | 1976 | 12 | 0.030 |
Why?
|
Hypospadias | 2 | 1975 | 78 | 0.030 |
Why?
|
Infant | 4 | 2006 | 12471 | 0.030 |
Why?
|
Margins of Excision | 1 | 2017 | 53 | 0.030 |
Why?
|
Vas Deferens | 1 | 1976 | 22 | 0.030 |
Why?
|
Drainage | 2 | 1975 | 258 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 1976 | 28 | 0.030 |
Why?
|
Foreign Bodies | 1 | 1977 | 104 | 0.030 |
Why?
|
Liposarcoma | 1 | 1976 | 22 | 0.030 |
Why?
|
Muscle Relaxation | 3 | 1980 | 16 | 0.030 |
Why?
|
Guinea Pigs | 3 | 1980 | 166 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 1976 | 45 | 0.030 |
Why?
|
Heart Atria | 2 | 1978 | 316 | 0.030 |
Why?
|
Pyelonephritis | 1 | 1976 | 26 | 0.030 |
Why?
|
Ankylosis | 1 | 1975 | 1 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 1979 | 361 | 0.030 |
Why?
|
Abdomen | 2 | 1986 | 127 | 0.030 |
Why?
|
Myelolipoma | 1 | 1995 | 3 | 0.030 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 1995 | 8 | 0.030 |
Why?
|
Hip Joint | 1 | 1975 | 37 | 0.030 |
Why?
|
Hemorrhage | 2 | 1976 | 467 | 0.030 |
Why?
|
Obstetric Labor Complications | 1 | 1976 | 93 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2007 | 8190 | 0.030 |
Why?
|
Diverticulitis, Colonic | 1 | 1974 | 7 | 0.030 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1995 | 61 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 1032 | 0.030 |
Why?
|
Surgical Instruments | 1 | 1974 | 55 | 0.030 |
Why?
|
Thorax | 1 | 1974 | 73 | 0.030 |
Why?
|
Treatment Failure | 1 | 1995 | 337 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2017 | 1428 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 1350 | 0.030 |
Why?
|
Fluorouracil | 1 | 1974 | 127 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 1976 | 215 | 0.030 |
Why?
|
Silicone Elastomers | 1 | 1973 | 35 | 0.030 |
Why?
|
Ostomy | 1 | 1993 | 11 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 1977 | 332 | 0.030 |
Why?
|
Patient Selection | 1 | 2017 | 693 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 1975 | 260 | 0.030 |
Why?
|
Databases, Factual | 1 | 2017 | 1177 | 0.030 |
Why?
|
Testis | 1 | 1974 | 407 | 0.020 |
Why?
|
Erythroplasia | 1 | 1992 | 2 | 0.020 |
Why?
|
Leukoplakia | 1 | 1992 | 3 | 0.020 |
Why?
|
Thoracic Surgery | 1 | 1974 | 161 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 1975 | 262 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 1992 | 71 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 1993 | 1882 | 0.020 |
Why?
|
Renal Dialysis | 1 | 1977 | 852 | 0.020 |
Why?
|
Linear Models | 1 | 2012 | 675 | 0.020 |
Why?
|
Stents | 2 | 1993 | 877 | 0.020 |
Why?
|
Electric Stimulation | 2 | 1980 | 325 | 0.020 |
Why?
|
Saudi Arabia | 2 | 1986 | 38 | 0.020 |
Why?
|
Laparoscopy | 1 | 1994 | 495 | 0.020 |
Why?
|
Parasympathetic Nervous System | 2 | 1980 | 15 | 0.020 |
Why?
|
Parasympatholytics | 2 | 1979 | 8 | 0.020 |
Why?
|
Receptors, Adrenergic | 2 | 1980 | 29 | 0.020 |
Why?
|
Histamine | 2 | 1979 | 44 | 0.020 |
Why?
|
Dogs | 3 | 1980 | 768 | 0.020 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2008 | 24 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2008 | 129 | 0.020 |
Why?
|
Digitalis Glycosides | 2 | 1979 | 5 | 0.020 |
Why?
|
Holmium | 1 | 2007 | 9 | 0.020 |
Why?
|
Biopsy | 3 | 1976 | 1237 | 0.020 |
Why?
|
In Vitro Techniques | 2 | 1979 | 969 | 0.020 |
Why?
|
Surgical Mesh | 1 | 1987 | 61 | 0.020 |
Why?
|
Pubic Bone | 1 | 1986 | 2 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2007 | 237 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2006 | 46 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2007 | 313 | 0.020 |
Why?
|
Calcium | 2 | 1985 | 1100 | 0.020 |
Why?
|
Urinary Calculi | 1 | 1985 | 18 | 0.020 |
Why?
|
Ligation | 2 | 1977 | 135 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 721 | 0.020 |
Why?
|
Administration, Oral | 1 | 2007 | 680 | 0.010 |
Why?
|
Anthropometry | 1 | 2005 | 199 | 0.010 |
Why?
|
Posture | 2 | 1975 | 154 | 0.010 |
Why?
|
Lymphatic Metastasis | 2 | 1994 | 414 | 0.010 |
Why?
|
Fistula | 2 | 1974 | 49 | 0.010 |
Why?
|
Cats | 2 | 1980 | 118 | 0.010 |
Why?
|
Isoproterenol | 2 | 1980 | 106 | 0.010 |
Why?
|
Norepinephrine | 2 | 1980 | 175 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 2050 | 0.010 |
Why?
|
Acetylcholine | 3 | 1977 | 83 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 10272 | 0.010 |
Why?
|
Rabbits | 2 | 1980 | 709 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1993 | 3552 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 3 | 1977 | 28 | 0.010 |
Why?
|
Prostaglandins E | 1 | 1980 | 8 | 0.010 |
Why?
|
Muscle Tonus | 1 | 1980 | 7 | 0.010 |
Why?
|
Prostaglandins F | 1 | 1980 | 9 | 0.010 |
Why?
|
Inflammation | 2 | 1978 | 1431 | 0.010 |
Why?
|
Neuromuscular Blocking Agents | 1 | 1979 | 6 | 0.010 |
Why?
|
Prochlorperazine | 1 | 1979 | 3 | 0.010 |
Why?
|
Depression, Chemical | 1 | 1979 | 43 | 0.010 |
Why?
|
Histamine Antagonists | 1 | 1979 | 16 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2001 | 168 | 0.010 |
Why?
|
Meningomyelocele | 1 | 1983 | 251 | 0.010 |
Why?
|
Angiomatosis | 1 | 1979 | 6 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1979 | 12 | 0.010 |
Why?
|
Bretylium Compounds | 1 | 1979 | 1 | 0.010 |
Why?
|
Guanethidine | 1 | 1979 | 2 | 0.010 |
Why?
|
Methyldopa | 1 | 1979 | 4 | 0.010 |
Why?
|
Phentolamine | 1 | 1979 | 20 | 0.010 |
Why?
|
Dihydroergotamine | 1 | 1979 | 10 | 0.010 |
Why?
|
von Hippel-Lindau Disease | 1 | 1979 | 20 | 0.010 |
Why?
|
Meprobamate | 1 | 1979 | 1 | 0.010 |
Why?
|
Paraldehyde | 1 | 1979 | 1 | 0.010 |
Why?
|
Chloral Hydrate | 1 | 1979 | 2 | 0.010 |
Why?
|
Phenothiazines | 1 | 1979 | 5 | 0.010 |
Why?
|
Meperidine | 1 | 1979 | 8 | 0.010 |
Why?
|
Reserpine | 1 | 1979 | 12 | 0.010 |
Why?
|
Nortriptyline | 1 | 1979 | 6 | 0.010 |
Why?
|
Strychnine | 1 | 1979 | 7 | 0.010 |
Why?
|
Picrotoxin | 1 | 1979 | 14 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1980 | 307 | 0.010 |
Why?
|
Amphetamines | 1 | 1979 | 10 | 0.010 |
Why?
|
Imipramine | 1 | 1979 | 18 | 0.010 |
Why?
|
Thyroid Hormones | 1 | 1979 | 67 | 0.010 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1979 | 25 | 0.010 |
Why?
|
Sialic Acids | 1 | 1979 | 20 | 0.010 |
Why?
|
Gonadal Steroid Hormones | 1 | 1979 | 88 | 0.010 |
Why?
|
Baclofen | 1 | 1979 | 39 | 0.010 |
Why?
|
Phenytoin | 1 | 1979 | 64 | 0.010 |
Why?
|
Ergotamine | 1 | 1978 | 1 | 0.010 |
Why?
|
Flavoxate | 1 | 1978 | 1 | 0.010 |
Why?
|
Propranolol | 1 | 1979 | 127 | 0.010 |
Why?
|
Dicyclomine | 1 | 1978 | 3 | 0.010 |
Why?
|
Levodopa | 1 | 1979 | 91 | 0.010 |
Why?
|
Chylous Ascites | 1 | 1978 | 11 | 0.010 |
Why?
|
Morphine | 1 | 1979 | 90 | 0.010 |
Why?
|
Angiotensins | 1 | 1978 | 8 | 0.010 |
Why?
|
Aminophylline | 1 | 1978 | 8 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2006 | 1893 | 0.010 |
Why?
|
Barium | 1 | 1978 | 17 | 0.010 |
Why?
|
Benzodiazepines | 1 | 1979 | 98 | 0.010 |
Why?
|
Bradykinin | 1 | 1978 | 59 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 1979 | 84 | 0.010 |
Why?
|
Prostaglandins | 1 | 1978 | 48 | 0.010 |
Why?
|
Calcium Phosphates | 1 | 1978 | 8 | 0.010 |
Why?
|
Anti-Anxiety Agents | 1 | 1979 | 74 | 0.010 |
Why?
|
Emepronium | 1 | 1978 | 1 | 0.010 |
Why?
|
Pentolinium Tartrate | 1 | 1978 | 1 | 0.010 |
Why?
|
Chlorisondamine | 1 | 1978 | 6 | 0.010 |
Why?
|
Hexamethonium Compounds | 1 | 1978 | 6 | 0.010 |
Why?
|
Tetraethylammonium Compounds | 1 | 1978 | 6 | 0.010 |
Why?
|
Mecamylamine | 1 | 1978 | 10 | 0.010 |
Why?
|
Neoplasm Metastasis | 2 | 1979 | 669 | 0.010 |
Why?
|
Chlorides | 1 | 1978 | 106 | 0.010 |
Why?
|
Anesthetics | 1 | 1979 | 80 | 0.010 |
Why?
|
Oxytocin | 1 | 1978 | 69 | 0.010 |
Why?
|
Glass | 1 | 1977 | 12 | 0.010 |
Why?
|
Injections | 1 | 1978 | 154 | 0.010 |
Why?
|
Action Potentials | 1 | 1980 | 501 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1978 | 154 | 0.010 |
Why?
|
Adrenergic Fibers | 1 | 1977 | 4 | 0.010 |
Why?
|
Hypogastric Plexus | 1 | 1977 | 7 | 0.010 |
Why?
|
Renal Artery | 1 | 1977 | 75 | 0.010 |
Why?
|
Neurons, Efferent | 1 | 1977 | 1 | 0.010 |
Why?
|
Ganglia, Autonomic | 1 | 1977 | 4 | 0.010 |
Why?
|
Urinary Tract Physiological Phenomena | 1 | 1977 | 2 | 0.010 |
Why?
|
Serotonin | 1 | 1978 | 225 | 0.010 |
Why?
|
Genital Diseases, Male | 1 | 1976 | 12 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 1978 | 204 | 0.010 |
Why?
|
Reflex | 1 | 1977 | 51 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 1977 | 50 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2005 | 3430 | 0.010 |
Why?
|
Receptors, Cholinergic | 1 | 1977 | 84 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 1977 | 63 | 0.010 |
Why?
|
Neuromuscular Junction | 1 | 1977 | 90 | 0.010 |
Why?
|
Ecchymosis | 1 | 1976 | 11 | 0.010 |
Why?
|
Necrosis | 1 | 1976 | 208 | 0.010 |
Why?
|
Rupture | 1 | 1976 | 33 | 0.010 |
Why?
|
Torsion Abnormality | 1 | 1976 | 34 | 0.010 |
Why?
|
Motor Neurons | 1 | 1977 | 141 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 1978 | 350 | 0.010 |
Why?
|
Epididymis | 1 | 1976 | 55 | 0.010 |
Why?
|
Polycystic Kidney Diseases | 1 | 1975 | 30 | 0.010 |
Why?
|
Organ Size | 1 | 1976 | 425 | 0.010 |
Why?
|
Needles | 1 | 1975 | 51 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 1 | 1977 | 350 | 0.010 |
Why?
|
Angiography | 1 | 1976 | 215 | 0.010 |
Why?
|
Fasciotomy | 1 | 1975 | 27 | 0.010 |
Why?
|
Blood Vessels | 1 | 1975 | 102 | 0.010 |
Why?
|
Hamartoma | 1 | 1975 | 52 | 0.010 |
Why?
|
Paraplegia | 1 | 1975 | 94 | 0.010 |
Why?
|
Hemangioma, Cavernous | 1 | 1974 | 19 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 1974 | 69 | 0.010 |
Why?
|
Apatites | 1 | 1974 | 1 | 0.010 |
Why?
|
Proteus Infections | 1 | 1974 | 7 | 0.010 |
Why?
|
Skin Transplantation | 1 | 1974 | 60 | 0.010 |
Why?
|
Endoscopes | 1 | 1974 | 20 | 0.010 |
Why?
|
Mycobacterium bovis | 1 | 1974 | 30 | 0.010 |
Why?
|
Oxalates | 1 | 1974 | 32 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1976 | 382 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1974 | 298 | 0.010 |
Why?
|
Magnesium | 1 | 1974 | 121 | 0.010 |
Why?
|
Diatrizoate | 1 | 1973 | 3 | 0.010 |
Why?
|
Phosphates | 1 | 1974 | 113 | 0.010 |
Why?
|
Rats | 1 | 1980 | 3676 | 0.010 |
Why?
|
Dermatitis | 1 | 1973 | 26 | 0.010 |
Why?
|
Cicatrix | 1 | 1974 | 123 | 0.010 |
Why?
|
Dilatation | 1 | 1973 | 64 | 0.010 |
Why?
|
Pregnancy | 2 | 1995 | 7180 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1975 | 184 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 1993 | 173 | 0.010 |
Why?
|
Skin Diseases | 1 | 1974 | 129 | 0.010 |
Why?
|
Pedigree | 1 | 1976 | 1605 | 0.010 |
Why?
|
Fever | 1 | 1973 | 296 | 0.010 |
Why?
|
Prospective Studies | 2 | 1985 | 6138 | 0.010 |
Why?
|
Immunotherapy | 1 | 1974 | 670 | 0.010 |
Why?
|
Intellectual Disability | 1 | 1975 | 1056 | 0.000 |
Why?
|
Length of Stay | 1 | 1973 | 1311 | 0.000 |
Why?
|
Prognosis | 1 | 1995 | 4625 | 0.000 |
Why?
|
Parathyroid Hormone | 1 | 1985 | 73 | 0.000 |
Why?
|
Brain | 1 | 1977 | 2982 | 0.000 |
Why?
|
Hospitalization | 1 | 1973 | 1777 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1985 | 246 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1985 | 432 | 0.000 |
Why?
|
Creatinine | 1 | 1985 | 390 | 0.000 |
Why?
|
Sex Characteristics | 1 | 1985 | 314 | 0.000 |
Why?
|
Circadian Rhythm | 1 | 1985 | 272 | 0.000 |
Why?
|
Metaraminol | 1 | 1978 | 1 | 0.000 |
Why?
|
Ephedrine | 1 | 1978 | 5 | 0.000 |
Why?
|
Phenylpropanolamine | 1 | 1978 | 4 | 0.000 |
Why?
|
Phenylephrine | 1 | 1978 | 38 | 0.000 |
Why?
|
Belladonna Alkaloids | 1 | 1977 | 1 | 0.000 |
Why?
|
Benactyzine | 1 | 1977 | 1 | 0.000 |
Why?
|
Propantheline | 1 | 1977 | 1 | 0.000 |
Why?
|
Hemicholinium 3 | 1 | 1977 | 3 | 0.000 |
Why?
|
Cyclohexanes | 1 | 1977 | 7 | 0.000 |
Why?
|
Atropine | 1 | 1977 | 31 | 0.000 |
Why?
|
Mandelic Acids | 1 | 1977 | 6 | 0.000 |
Why?
|
Bethanechol Compounds | 1 | 1977 | 2 | 0.000 |
Why?
|
Methacholine Compounds | 1 | 1977 | 2 | 0.000 |
Why?
|
Physostigmine | 1 | 1977 | 9 | 0.000 |
Why?
|
Muscarine | 1 | 1977 | 6 | 0.000 |
Why?
|
Carbachol | 1 | 1977 | 18 | 0.000 |
Why?
|
Pyridinium Compounds | 1 | 1977 | 20 | 0.000 |
Why?
|
Neostigmine | 1 | 1977 | 6 | 0.000 |
Why?
|
Drug Interactions | 1 | 1978 | 254 | 0.000 |
Why?
|
Epinephrine | 1 | 1978 | 179 | 0.000 |
Why?
|
Connective Tissue | 1 | 1977 | 22 | 0.000 |
Why?
|
Basement Membrane | 1 | 1977 | 48 | 0.000 |
Why?
|
Dopamine | 1 | 1978 | 284 | 0.000 |
Why?
|
Cholinesterase Inhibitors | 1 | 1977 | 100 | 0.000 |
Why?
|
Cytoplasm | 1 | 1977 | 290 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1975 | 65 | 0.000 |
Why?
|
Haplorhini | 1 | 1975 | 123 | 0.000 |
Why?
|
Macaca | 1 | 1975 | 61 | 0.000 |
Why?
|
Protein Binding | 1 | 1979 | 1738 | 0.000 |
Why?
|